CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
Why Is CVS Health (CVS) Up 8.3% Since Last Earnings Report?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Cheap Stocks Under $10 to Buy Now for Coronavirus Reopening Rally
by Benjamin Rains
Today we look at three "cheap" stocks trading under $10 a share that might be worth buying as the market continues to march higher on coronavirus reopening optimism and more...
Zacks.com featured highlights include: Vertex Pharmaceuticals, Dollar General, CVS Health and Tractor Supply
by Zacks Equity Research
Zacks.com featured highlights include: Vertex Pharmaceuticals, Dollar General, CVS Health and Tractor Supply
4 Stocks That Flaunt an Impressive Interest Coverage Ratio
by Sumit Singh
Interest coverage ratio is used to determine how effectively a company can pay the interest charged on its debt.
Molina Healthcare's New Deal to Boost Its Medicaid Business
by Zacks Equity Research
Molina Healthcare's (MOH) new agreement intends to efficiently serve its Medicaid members, which, in turn, will likely boost its market presence.
Consumer Confidence Sees Revival in May: Here's What it Means
by Zacks.com
It seems that consumers' confidence got restored in May as lockdowns were eased and businesses gradually reopened. Government stimulus helped companies weather the coronavirus crisis and improve their customer sentiments.
Are Investors Undervaluing CVS Health (CVS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cigna Adds Capabilities to Expand Its Virtual Care Service
by Zacks Equity Research
Cigna (CI) has added a private messaging application to better serve its members amid COVID-19 breakout.
The Zacks Analyst Blog Highlights: NVIDIA, Coca-Cola, PetroChina, CVS Health and Zoom Video Communications
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NVIDIA, Coca-Cola, PetroChina, CVS Health and Zoom Video Communications
Q1 Scorecard and Research Reports for NVIDIA, Coca-Cola, PetroChina & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA (NVDA), Coca-Cola (KO) and PetroChina (PTR).
Cigna (CI) Dispenses Digital Services to Fight Coronavirus
by Zacks.com
Cigna (CI) offers digital solutions to facilitate real-time support to its customers for tracking coronavirus symptoms.
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks - May 11, 2020
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Stock Market News for May 7, 2020
by Zacks Equity Research
Benchmarks closed mixed on Wednesday as data showed that private payroll had furloughed more than 20 million workers in April, highlighting the economic impact of the pandemic.
CVS Health (CVS) Q1 Earnings Top Estimates, Costs Escalate
by Zacks Equity Research
Within CVS Health's (CVS) Retail/LTC, the coronavirus pandemic results in greater use of 90-day prescriptions and early refills of maintenance medications in the quarter.
CVS Health (CVS) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 17.18% and 5.74%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Microsoft, CVS, Boeing, Facebook and Sherwin-Williams
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, CVS, Boeing, Facebook and Sherwin-Williams
What's in the Cards for CVS Health (CVS) in Q1 Earnings?
by Zacks Equity Research
We expect CVS Health (CVS) to have gained from Aetna's addition of new Individual and Group Medicare Advantage members in Q1.
Top Research Reports for Microsoft, CVS Health & Boeing
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), CVS Health (CVS) and Boeing (BA).
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $63.43, moving +0.3% from the previous trading session.
CVS Health (CVS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income - April 29, 2020
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $61.31, moving +1.59% from the previous trading session.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks - April 23, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Rite Aid (RAD) Expands Coronavirus Testing Site to Virginia
by Zacks Equity Research
Rite Aid (RAD) is aggressively expanding COVID-19 testing locations, marked by the opening of its 25th site at Richmond, VA, to help curb the effects of the pandemic.
Rite Aid's (RAD) Q4 Loss Wider Than Expected, Sales Rise Y/Y
by Zacks Equity Research
Strong revenues at pharmacy services and retail pharmacy segments aided Rite Aid's (RAD) Q4 results. Further, management issued FY21 view, which reflects no COVID-19 impacts.